Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Birgit K Skovbjerg1, Ole Kl Helgestad2, Christina S Oxlund2

  • 1Øre, Næse og Halsafdelingen, Københavns Universitetshospital - Nordsjællands Hospital, Hillerød.

Ugeskrift for Laeger
|April 28, 2023
PubMed
Summary

Reducing amlodipine dosage significantly lowers pedal edema risk. Management options include dosage reduction, switching medications, or non-pharmacologic approaches for mild cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

General practitioners' awareness of familial hypercholesterolemia: a full-text audit of management patterns in Danish general practice.

BJGP open·2026
Same author

Socioeconomic Differences in Patient Pathways of Secondary Prevention after Ischaemic Heart Disease: A Nationwide Cohort Study.

European journal of preventive cardiology·2026
Same author

Healthcare activities before familial hypercholesterolemia diagnosis: a nationwide register-based study in Denmark.

BMC primary care·2026
Same author

Ugeskrift for laeger·2025
Same author

Identifying rehabilitation needs as part of secondary prevention in individuals with Atrial Fibrillation - a Delphi consensus study.

European journal of preventive cardiology·2025
Same author

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.

Acta oncologica (Stockholm, Sweden)·2025

Area of Science:

  • Cardiovascular medicine
  • Pharmacology

Background:

  • Pedal oedema is a common adverse effect of amlodipine.
  • Diuretics are generally ineffective for managing amlodipine-induced pedal oedema.

Approach:

  • This review prioritizes strategies to minimize side effects.
  • It outlines various management options for amlodipine-induced pedal oedema.

Key Points:

  • Reducing amlodipine dosage to half the maximum recommended dose can significantly decrease the incidence of pedal oedema.
  • Effective management strategies include dose reduction, switching to alternative antihypertensives like lercanidipine or lacidipine, or changing to a different drug class.
  • Adding or increasing the dosage of ACE-inhibitors or angiotensin II-receptor blockers, administering amlodipine at night, or switching to verapamil or diltiazem are also viable options.
  • Non-pharmacologic interventions or observation are suitable for mild, non-bothersome oedema.

Conclusions:

  • Minimizing amlodipine dosage is key to preventing pedal oedema.
  • A stepwise approach, starting with dose reduction and progressing to alternative medications or strategies, is recommended for effective management.

Related Experiment Videos